BNP Paribas’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.75M Buy
24,354
+14,130
+138% +$1.09M 0.06% 152
2025
Q4
$811K Buy
10,224
+7,624
+293% +$601K 0.02% 190
2025
Q3
$196K Buy
2,600
+1,600
+160% +$110K 0.01% 217
2025
Q2
$69K Hold
1,000
﹤0.01% 257
2025
Q1
$67.8K Sell
1,000
-600
-38% -$35.9K ﹤0.01% 259
2024
Q4
$71.8K Buy
1,600
+700
+78% +$39.3K ﹤0.01% 276
2024
Q3
$56.6K Sell
900
-100
-10% -$5.83K ﹤0.01% 269
2024
Q2
$59.1K Sell
1,000
-4,584
-82% -$287K ﹤0.01% 256
2024
Q1
$445K Buy
+5,584
New +$427K 0.02% 208

Other funds holding CVS

BNP Paribas's CVS Position: Q1 2026 in Review

BNP Paribas increased its CVS Health (CVS) stake by 138% in Q1 2026, buying an estimated $1.09M and bringing the position to 24,354 shares worth $1.75M. The position accounts for 0.06% of the portfolio, ranked #152.

BNP Paribas first reported a position in CVS in Q1 2024 and has held it in 9 quarters since. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • BNP Paribas held 24,354 shares of CVS Health worth $1.75M as of Q1 2026.
  • BNP Paribas bought 14,130 CVS Health shares in Q1 2026, an estimated $1.09M.
  • CVS Health made up 0.06% of BNP Paribas's portfolio in Q1 2026, its #152 holding.
  • BNP Paribas first reported a position in CVS Health in Q1 2024 and has held it in 9 quarters since.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.